Literature DB >> 27655886

Highlights of the 11th International Bordetella Symposium: from Basic Biology to Vaccine Development.

Nicholas H Carbonetti1, Carl Heinz Wirsing von König2, Ruiting Lan3, Francoise Jacob-Dubuisson4, Peggy A Cotter5, Rajendar Deora6, Tod J Merkel7, Cécile A van Els8, Camille Locht4, Daniela Hozbor9, Maria E Rodriguez10.   

Abstract

Pertussis is a severe respiratory disease caused by infection with the bacterial pathogen Bordetella pertussis The disease affects individuals of all ages but is particularly severe and sometimes fatal in unvaccinated young infants. Other Bordetella species cause diseases in humans, animals, and birds. Scientific, clinical, public health, vaccine company, and regulatory agency experts on these pathogens and diseases gathered in Buenos Aires, Argentina from 5 to 8 April 2016 for the 11th International Bordetella Symposium to discuss recent advances in our understanding of the biology of these organisms, the diseases they cause, and the development of new vaccines and other strategies to prevent these diseases. Highlights of the meeting included pertussis epidemiology in developing nations, genomic analysis of Bordetella biology and evolution, regulation of virulence factor expression, new model systems to study Bordetella biology and disease, effects of different vaccines on immune responses, maternal immunization as a strategy to prevent newborn disease, and novel vaccine development for pertussis. In addition, the group approved the formation of an International Bordetella Society to promote research and information exchange on bordetellae and to organize future meetings. A new Bordetella.org website will also be developed to facilitate these goals.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27655886      PMCID: PMC5098017          DOI: 10.1128/CVI.00388-16

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  33 in total

Review 1.  Duration of immunity against pertussis after natural infection or vaccination.

Authors:  Aaron M Wendelboe; Annelies Van Rie; Stefania Salmaso; Janet A Englund
Journal:  Pediatr Infect Dis J       Date:  2005-05       Impact factor: 2.129

2.  Pertactin deficient Bordetella pertussis present a better fitness in mice immunized with an acellular pertussis vaccine.

Authors:  N Hegerle; G Dore; N Guiso
Journal:  Vaccine       Date:  2014-10-11       Impact factor: 3.641

3.  Pertactin-negative variants of Bordetella pertussis in the United States.

Authors:  Anne Marie Queenan; Pamela K Cassiday; Alan Evangelista
Journal:  N Engl J Med       Date:  2013-02-07       Impact factor: 91.245

4.  Pertactin-negative Bordetella pertussis strains in Canada: characterization of a dozen isolates based on a survey of 224 samples collected in different parts of the country over the last 20 years.

Authors:  Raymond S W Tsang; Michelle Shuel; Frances B Jamieson; Steven Drews; Linda Hoang; Greg Horsman; Brigitte Lefebvre; Shalini Desai; Monique St-Laurent
Journal:  Int J Infect Dis       Date:  2014-09-22       Impact factor: 3.623

5.  Effect of acetazolamide on cough induced by low-chloride-ion solutions in normal subjects: comparison with furosemide.

Authors:  A Foresi; G Cavigioli; A Pelucchi; B Mastropasqua; L Marazzini
Journal:  J Allergy Clin Immunol       Date:  1996-05       Impact factor: 10.793

6.  Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children.

Authors:  C L Cody; L J Baraff; J D Cherry; S M Marcy; C R Manclark
Journal:  Pediatrics       Date:  1981-11       Impact factor: 7.124

Review 7.  Bordetella biofilms: a lifestyle leading to persistent infections.

Authors:  Natalia Cattelan; Purnima Dubey; Laura Arnal; Osvaldo M Yantorno; Rajendar Deora
Journal:  Pathog Dis       Date:  2015-11-19       Impact factor: 3.166

8.  Prevalence and genetic characterization of pertactin-deficient Bordetella pertussis in Japan.

Authors:  Nao Otsuka; Hyun-Ja Han; Hiromi Toyoizumi-Ajisaka; Yukitsugu Nakamura; Yoshichika Arakawa; Keigo Shibayama; Kazunari Kamachi
Journal:  PLoS One       Date:  2012-02-14       Impact factor: 3.240

Review 9.  Pertussis resurgence: waning immunity and pathogen adaptation - two sides of the same coin.

Authors:  F R Mooi; N A T Van Der Maas; H E De Melker
Journal:  Epidemiol Infect       Date:  2013-02-13       Impact factor: 4.434

10.  Adaptation of Bordetella pertussis to vaccination: a cause for its reemergence?

Authors:  F R Mooi; I H van Loo; A J King
Journal:  Emerg Infect Dis       Date:  2001       Impact factor: 6.883

View more
  6 in total

Review 1.  Bordetella Pertussis virulence factors in the continuing evolution of whooping cough vaccines for improved performance.

Authors:  Dorji Dorji; Frits Mooi; Osvaldo Yantorno; Rajendar Deora; Ross M Graham; Trilochan K Mukkur
Journal:  Med Microbiol Immunol       Date:  2017-11-21       Impact factor: 3.402

2.  Highlights of the 12th International Bordetella Symposium.

Authors:  Camille Locht; Nicholas H Carbonetti; James D Cherry; F Heath Damron; Kathryn M Edwards; Rachel Fernandez; Eric T Harvill; Daniela Hozbor; Kingston H G Mills; Maria Eugenia Rodriguez; Françoise Mascart
Journal:  Clin Infect Dis       Date:  2020-12-03       Impact factor: 9.079

3.  Pertussis diagnosis in Belgium: results of the National Reference Centre for Bordetella anno 2015.

Authors:  H Martini; C Rodeghiero; C VAN DEN Poel; M Vincent; D Pierard; K Huygen
Journal:  Epidemiol Infect       Date:  2017-06-05       Impact factor: 4.434

4.  Whole-Cell or Acellular Pertussis Primary Immunizations in Infancy Determines Adolescent Cellular Immune Profiles.

Authors:  Saskia van der Lee; Lotte H Hendrikx; Elisabeth A M Sanders; Guy A M Berbers; Anne-Marie Buisman
Journal:  Front Immunol       Date:  2018-01-24       Impact factor: 7.561

Review 5.  Acellular Pertussis Vaccine Components: Today and Tomorrow.

Authors:  Kalyan K Dewan; Bodo Linz; Susan E DeRocco; Eric T Harvill
Journal:  Vaccines (Basel)       Date:  2020-05-13

6.  Genomic Sequencing of Bordetella pertussis for Epidemiology and Global Surveillance of Whooping Cough.

Authors:  Valérie Bouchez; Julien Guglielmini; Mélody Dazas; Annie Landier; Julie Toubiana; Sophie Guillot; Alexis Criscuolo; Sylvain Brisse
Journal:  Emerg Infect Dis       Date:  2018-06       Impact factor: 6.883

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.